Additionally, elevated levels of IL-6, and TNF-α, are observed in HCC patients and are associated with inflammation-driven carcinogenesis, activation of oncogenic pathways (e.g., STAT3), and poor prognosis (Kao et al., 2015). This evidence concerns the gene TNF and hepatocellular carcinoma.